- Type / Class
- Equity / Common Stock
- Shares outstanding
- 353,007,843
- Total 13F shares
- 60,722,436
- Share change
- -967,397
- Total reported value
- $95,930,395
- Put/Call ratio
- 18%
- Price per share
- $1.58
- Number of holders
- 130
- Value change
- -$1,354,697
- Number of buys
- 56
- Number of sells
- 49
Quarterly Holders Quick Answers
What is CUSIP 74017N105?
CUSIP 74017N105 identifies PGEN - PRECIGEN, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74017N105:
Top shareholders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ares Trading S.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
20,647,152
|
$29,112,484 | — | 12 Oct 2021 | |
| Patient Capital Management, LLC |
13F
|
Company |
4.9%
|
17,453,455
|
$25,307,509 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
10,363,128
|
$15,026,535 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
6,768,234
|
$9,813,939 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.86%
|
3,030,885
|
$4,395,279 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.8%
|
2,825,450
|
$4,096,903 | — | 31 Mar 2024 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
0.59%
|
2,091,274
|
$3,032,347 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.51%
|
1,784,886
|
$2,588,085 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.39%
|
1,370,451
|
$1,987,154 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.37%
|
1,294,704
|
$1,877,321 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.31%
|
1,082,317
|
$1,569,360 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
1,068,527
|
$1,549,364 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
1,063,328
|
$1,541,825 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.3%
|
1,052,190
|
$1,526,000 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.27%
|
947,500
|
$1,373,875 | — | 31 Mar 2024 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.2%
|
705,000
|
$1,022,250 | — | 31 Mar 2024 | |
| Dean J. Mitchell |
3/4/5
|
Director |
—
mixed-class rows
|
692,221
mixed-class rows
|
$844,551 | — | 14 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.15%
|
534,983
|
$775,725 | — | 31 Mar 2024 | |
| EMFO, LLC |
13F
|
Company |
0.15%
|
519,475
|
$753,239 | — | 31 Mar 2024 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.14%
|
478,400
|
$693,680 | — | 31 Mar 2024 | |
| Robert B. Shapiro |
3/4/5
|
Director |
—
mixed-class rows
|
596,438
mixed-class rows
|
$657,116 | — | 09 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
402,487
|
$583,607 | — | 31 Mar 2024 | |
| MSD Partners, L.P. |
13F
|
Company |
0.1%
|
355,000
|
$514,750 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
317,256
|
$460,021 | — | 31 Mar 2024 | |
| Fore Capital, LLC |
13F
|
Company |
0.09%
|
306,791
|
$444,847 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.08%
|
298,642
|
$433,030 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
284,436
|
$412,433 | — | 31 Mar 2024 | |
| Cetera Investment Advisers |
13F
|
Company |
0.07%
|
260,512
|
$377,742 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.07%
|
255,635
|
$370,671 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.06%
|
223,288
|
$324,000 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
203,137
|
$294,539 | — | 31 Mar 2024 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.06%
|
199,255
|
$288,920 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
184,770
|
$267,917 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
169,915
|
$246,377 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.05%
|
165,152
|
$240,000 | — | 31 Mar 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.05%
|
166,171
|
$237,625 | — | 31 Mar 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.04%
|
156,213
|
$226,509 | — | 31 Mar 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.04%
|
153,499
|
$222,574 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
132,190
|
$191,676 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
113,296
|
$164,279 | — | 31 Mar 2024 | |
| Summit Trail Advisors, LLC |
13F
|
Company |
0.03%
|
104,529
|
$151,567 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.03%
|
100,000
|
$145,000 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
97,231
|
$140,984 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
91,943
|
$133,317 | — | 31 Mar 2024 | |
| LexAurum Advisors, LLC |
13F
|
Company |
0.03%
|
89,166
|
$129,291 | — | 31 Mar 2024 | |
| CARY STREET PARTNERS INVESTMENT ADVISORY LLC |
13F
|
Company |
0.02%
|
85,873
|
$124,516 | — | 31 Mar 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.02%
|
78,184
|
$113,000 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.02%
|
71,464
|
$103,623 | — | 31 Mar 2024 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.02%
|
68,764
|
$99,708 | — | 31 Mar 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
67,669
|
$98,120 | — | 31 Mar 2024 |
Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q2 2024
As of 30 Jun 2024,
PRECIGEN, INC. - Common Stock (PGEN) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,722,436 shares.
The largest 10 holders included
Patient Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, IRIDIAN ASSET MANAGEMENT LLC/CT, D. E. Shaw & Co., Inc., RENAISSANCE TECHNOLOGIES LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and JPMORGAN CHASE & CO.
This page lists
130
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
127
Q2 2024 holders
130
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.